Overview
Study information
Network: | CAVD |
Grant Affiliation: | Reinherz: bNAbs Against Clade C |
Strategy: | Prophylactic neutralizing Ab |
Study Type: | Antibody Screening |
Species: | Non-Organism Study |
Stage: | Assays Completed |
Study Start Date: | 2010-04-05 |
Study Made Public: | 2013-05-21 |
Title
Reinherz_Kim_MPER mutants
Description
CAVD 245 evaluates how sequence changes in the MPER of gp41 affect MPER conformation and neutralization sensitivity by anti-MPER broadly neutralizing antibodies.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
NAb MAb
Non-integrated data
No non-integrated data is available for this study.